Stents Global Market- Forecast to 2027

Publishing Date : February, 2021
Report Code : HCMD0130
Price:
Single license $4950
Site license $6750
Global license $9000


Note: The report would be dispatched after confirmation of payment

Stents are the miniaturized, flexible or expandable tube like structures used to widen and establish patency of the clogged vascular or non-vascular tubular structures and to ensure steady flow of body fluids through them. Compared to the traditional highly invasive surgical repair procedures, the current minimally invasive transcatheter therapeutic procedures with highly efficient, technologically advanced stent products assure patients and healthcare providers with improved efficiency, effectiveness and quicker restoration of the narrowed vessel’s or duct’s natural function. Increased utilization of the various stent products for the numerous and varied types of vascular and non-vascular obstructive conditions and cerebral aneurysm among the patients, elevating inclination of the value centric global patient pool towards the minimally invasive, technologically advanced stent products with better therapeutic outcomes and the need to rapidly mitigate the clinical manifestations associated with blocked vascular and non-vascular hollow organs or weakened vascular bed, reduce hospitalization duration and ease and improve the patient’s condition quickly through efficient and safer interventional products are fuelling the stents global market.

As estimated by IQ4I Research, the stents global market is expected to reach $13,522.8 million by 2027 growing at a mid single digit CAGR from 2020 to 2027, due to increasing prevalence of various kinds of stenotic diseases and cerebral aneurysm across the globe, increasing demand for highly efficient, minimally invasive therapeutic products from the value centric patient population, the trend of coronary stent price slashing and increasing competitiveness of the domestic players in some of the major APAC countries, favorable reimbursement scenario in developed nations, emergence of technologically advanced stent products, persistently escalating geriatric population and the feasibility of even drug eluting stents (DES) in them and the numerous acquisitions and distribution agreements among the stent companies, developing healthcare infrastructural facilities and increasing demand for better healthcare services in the emerging markets. The stents market is segmented by product, material, application, end-users and geography.

Based on the product, the stents global market is segmented into bare metal stents, drug eluting stents (DES), bioresorbable stents and other stents consisting of covered stents and the non-drug eluting polymeric stents. Among these products, the drug eluting stents segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 due to increasing popularity and adoption of the highly efficient DES across the globe and the constant technological and engineering improvements in these stent products. Bioresorbable stents segment is the fastest emerging segment and is expected of growing at a low teen CAGR during the forecasted period due to increasing research and development activities for the development of highly efficient and safer biodegradable stents that will gradually disappear after improving the patency of the narrowed vessel or duct.

Based on the materials used, the stents global market is segmented into metal alloy based stents and polymer based stents. The metal alloy based stents is further categorized into cobalt-chrome alloy stents, nitinol or nickel-titanium alloy stents, platinum-chromium alloy stents, stainless steel stents and other metallic biomaterial stents like those made up of magnesium, iron and others. The polymer based stents includes stents made up of durable or biostable polymers and biodegradable polymers. In the overall stents market based on materials, the metal alloy based stents segment accounted for the largest share in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 due to the increasing utilization of various metallic materials in the production of bare metal stents (BMS), drug eluting stents (DES), covered stents and even the bioresorbable stents and the exhibition of the most desirable and advantageous stent characteristics like high tensile or mechanical strength, elasticity, rigidity and radiopacity by the metallic biomaterials. Among metal alloy based stents, cobalt-chrome alloy stents segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 while nitinol alloy stents segment is the fastest emerging segment and is expected of growing at a mid single digit CAGR from 2020 to 2027. Polymer based stents segment is the fastest emerging segment growing at a high single digit CAGR from 2020 to 2027 due to the escalating utilization of polymers in the manufacturing of DES, covered stents, polymeric non drug eluting stents and the polymeric bioresorbable stents and the manifestation of stent advantageous characteristics like flexibility, elasticity and the controlled drug elution kinetics by the polymers. Among the different kinds of polymer based stents, durable polymer based stents segment accounted for the largest revenue in 2020 and is expected to grow at a high single digit CAGR during the forecasted period while biodegradable polymer based stents segment is the fastest emerging segment growing at a low teen CAGR from 2020 to 2027.

Based on the application, stents global market is broadly classified as vascular and non-vascular stents. Among these, the vascular stents segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 due to the persistently elevating prevalence of vascular stenotic conditions and cerebral aneurysm across the globe that is in need of various rapid, efficient, technologically advanced and minimally traumatizing therapeutic interventions like stenting. The vascular stents are further segmented into coronary artery stents, peripheral artery stents, neurovascular stents and others consisting of venous stents, vertebral artery stents and pulmonary artery stents. Among these, the coronary artery stent segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 while neurovascular stents segment is the fastest emerging segment and is expected of growing at a high single digit CAGR from 2020 to 2027. Neurovascular stents can be further classified into carotid artery stents, intracranial stents and flow diverter stents for treating cerebral aneurysms. Among the various neurovascular stents, carotid artery stents accounted for the largest revenue in 2020 and is expected to grow at double digit CAGR during 2020 to 2027. Based on the application type, non-vascular stents are segmented into gastrointestinal stents, urinary tract stents or urological stents, airway or tracheobronchial stents or pulmonary stents and others consisting of ophthalmic stents. Among these, the gastrointestinal stents (GI) segment accounted for the largest revenue in 2020 and is expected to grow at a low single digit CAGR from 2020 to 2027. GI stents are further segmented as pancreatic and biliary stents, colonic or colorectal stents, esophageal stents and duodenal stents. Among these, the Pancreatic & Biliary Stents segment accounted for the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027.

Based on the end-users, the stents global market is divided into Hospitals; Ambulatory surgery centers (ASCs) and others consisting of Freestanding or mobile Catheterization Labs and Research Institutes. Among the various end-users, Hospitals segment accounted for the largest revenue in 2020 and is expected to grow at a low single digit CAGR during the period 2020 to 2027 due to increased utilization of various types of stent products for the stenting procedures performed in the hospital associated in-patient or out-patient settings. Ambulatory Surgery Centers (ASCs) segment is the fastest emerging segment and is expected of growing at a mid single digit CAGR from 2020 to 2027.

Based on the region, the stents global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, Italy and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and Rest of the world (Brazil, Turkey, Rest of Latin America and Middle East & Africa). The major share of the stents global market is occupied by Asia-Pacific in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027 mainly due to the persistently elevating prevalence of vascular and non-vascular stenotic conditions in the region, increasing affordability and accessibility of the major stent products like coronary stents among the patients of some of the major countries in the region attributed to government imposed price slashing measures for these life-saving devices, elevating geriatric population impaired with various kinds of vascular or non-vascular obstructive diseases, increasing patient awareness and demand for better, quick minimally invasive, efficient therapeutic procedures with advanced therapeutic products, growing economies of the region, persistently developing healthcare infrastructural facilities in the region, increasing healthcare expenditures and medical tourism aspects of the region. Rest of World (ROW) is the fastest emerging region and is expected of growing at a high single digit CAGR during the forecasted period. The rapid market growth rate of stents market in this region is due to escalating prevalence of vasculature and duct system associated obstructive conditions in the region, increasing geriatric population loaded with various kinds of stenotic conditions, increasing patient awareness and demand for better, quick minimally invasive therapeutic procedures and efficient therapeutic products, growing economies of the region, increasing per capita expenditure on healthcare needs and medical tourism prospects of the region.

The stents global market is consolidated with few companies dominating and occupying major share of the market. Some of the leading players in stents market are Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Cook Medical LLC (U.S.), Cardinal Health Inc. (U.S.), Becton, Dickinson and company (U.S.), B. Braun Melsungen AG (Germany), Biotronik SE & Co.KG (Germany), Blue Sail Medical Co. Ltd (Biosensors International Pte Ltd) (China) and others.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Rest of North America
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia-Pacific 
  • China
  • Japan
  • India
  • Rest of APAC
  • Rest of the World (RoW)
  • Brazil
  • Turkey
  • Rest of LATAM and Middle East and Africa
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     ESCALATING PREVALENCE OF VASCULAR AND NON-VASCULAR STENOTIC DISEASES AND CEREBRAL ANEURYSM
        • 3.3.1.2     ELEVATING INCLINATION TOWARDS MINIMALLY INVASIVE THERAPEUTIC APPROACHES
        • 3.3.1.3     THE TREND OF CORONARY STENT PRICE SLASHING AND INCREASING COMPETITIVENESS OF DOMESTIC PLAYERS IN APAC COUNTRIES
        • 3.3.1.4     EMERGENCE OF TECHNOLOGICALLY ADVANCED PRODUCTS
        • 3.3.1.5     ESCALATING GERIATRIC POPULATION AND FEASIBILITY OF DRUG ELUTING STENTS IN THEM
        • 3.3.1.6     ACQUISITIONS AND DISTRIBUTION AGREEMENTS TO OPEN AN ARRAY OF OPPORTUNITIES FOR THE MARKET TO FLOURISH
        • 3.3.1.7     FAVOURABLE REIMBURSEMENT POLICIES ESCALATING STENT TECHNOLOGY DIFFUSION IN DEVELOPED NATIONS
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     STRINGENT REGULATORY BODIES GUIDING STENT MANUFACTURERS
        • 3.3.2.2     THE THREAT OF COMMERCIALIZED STENT RECALLS
        • 3.3.2.3     LACK OF SKILLED, EXPERIENCED AND TRAINED HEALTHCARE PROFESSIONALS
        • 3.3.2.4     ADVERSE EFFECTS OF STENTS
        • 3.3.2.5     CONCERNS OVER IRRATIONAL STENTING AND UNDER-PERFORMANCE OF STENTS IN COMPLEX STENOTIC DISEASES OR LESIONS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
        • 3.4.1.2     ISO 14644-1 CLEAN ROOM STANDARDS
        • 3.4.1.3     ISO 13485 MEDICAL DEVICES
        • 3.4.1.4     ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
        • 3.4.1.5     ISO 14971: RISK MANAGEMENT OF MEDICAL DEVICES
        • 3.4.1.6     ISO 25539-2:2020 CARDIOVASCULAR IMPLANTS — ENDOVASCULAR DEVICES — PART 2: VASCULAR STENTS
        • 3.4.1.7     ISO 25539-1
        • 3.4.1.8     ISO 12417-1
        • 3.4.1.9     ISO/TS 17137
        • 3.4.1.10     ISO 17327-1
        • 3.4.1.11     IEC 60601-1 MEDICAL ELECTRICAL EQUIPMENT STANDARD
      • 3.4.2     ASTM INTERNATIONAL STANDARDS
      • 3.4.3     U.S.
      • 3.4.4     CANADA
      • 3.4.5     EUROPE
      • 3.4.6     JAPAN
      • 3.4.7     CHINA
      • 3.4.8     INDIA
    • 3.5     TECHNOLOGICAL ADVANCEMENTS
      • 3.5.1     INTRODUCTION
      • 3.5.2     SMART STENTS
      • 3.5.3     3D-PRINTED STENTS
      • 3.5.4     INDIRECT 4D PRINTING AND MICROSTENTS
      • 3.5.5     NANOCOATED NON-DRUG ELUTING STENT AND ULTRASHORT DAPT
      • 3.5.6     BIOENGINEERED STENTS
      • 3.5.7     GENE ELUTING STENTS (GES)
      • 3.5.8     BIORESORBABLE STENTS
    • 3.6     STENTS COATING MATERIALS
      • 3.6.1     INORGANIC COATING MATERIALS
      • 3.6.2     ORGANIC COATING MATERIALS
      • 3.6.3     BIOLOGICAL COATING MATERIALS OR BIOCOATINGS
      • 3.6.4     CHEMOTHERAPUTICS OR DRUGS
    • 3.7     PORTER’S FIVE FORCE ANALYSIS
      • 3.7.1     THREAT OF NEW ENTRANTS
      • 3.7.2     THREAT OF SUBSTITUTES
      • 3.7.3     BARGAINING POWER OF SUPPLIERS
      • 3.7.4     BARGAINING POWER OF BUYERS
      • 3.7.5     COMPETITIVE RIVALRY
    • 3.8     SUPPLY CHAIN ANALYSIS
    • 3.9     REIMBURSEMENT SCENARIO
    • 3.1     PATENT TRENDS
    • 3.11     REGULATORY APPROVAL ANALYSIS
    • 3.12     CLINICAL TRIALS
    • 3.13     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.13.1     STENTS GLOBAL MARKET SHARE ANALYSIS
      • 3.13.2     CORONARY STENTS GLOBAL MARKET SHARE ANALYSIS
      • 3.13.3     PERIPHERAL STENTS GLOBAL MARKET SHARE ANALYSIS
      • 3.13.4     NEUROVASCULAR STENTS GLOBAL MARKET SHARE ANALYSIS
        • 3.13.4.1     FLOW DIVERTERS GLOBAL MARKET SHARE ANALYSIS
        • 3.13.4.2     INTRACRANIAL STENT GLOBAL MARKET SHARE ANALYSIS
        • 3.13.4.3     CAROTID STENT GLOBAL MARKET SHARE ANALYSIS
      • 3.13.5     GASTROINTESTINAL STENTS GLOBAL MARKET SHARE ANALYSIS
      • 3.13.6     DRUG ELUTING STENTS GLOBAL MARKET SHARE ANALYSIS
    • 3.14     STENTS - NUMBER OF PROCEDURES BY REGION
      • 3.14.1     CORONARY STENT IMPLANTATION PROCEDURAL VOLUME BY REGION
      • 3.14.2     PERIPHERAL STENT IMPLANTATION PROCEDURAL VOLUME BY REGION
    • 3.15     STENTS COMPANY COMPARISON TABLE BY REVENUE, PRODUCT, PRODUCT TYPE, APPLICATION, MATERIAL AND INDICATION
  • 4     STENTS GLOBAL MARKET, BY PRODUCT
    • 4.1     INTRODUCTION
    • 4.2     BARE METAL STENTS
    • 4.3     DRUG ELUTING STENTS
    • 4.4     BIORESORBABLE STENTS
    • 4.5     OTHER STENTS (COVERED METALLIC STENTS AND POLYMERIC NON-DRUG ELUTING STENTS)
  • 5     STENTS GLOBAL MARKET, BY MATERIAL
    • 5.1     INTRODUCTION
    • 5.2     METAL ALLOY BASED STENTS
      • 5.2.1     COBALT CHROME ALLOY STENTS
      • 5.2.2     NITINOL ALLOY STENTS
      • 5.2.3     STAINLESS STEEL STENTS
      • 5.2.4     PLATINUM ALLOY STENTS
      • 5.2.5     OTHER METAL ALLOY STENTS (TANTALUM, MAGNESIUM, IRON AND METALLIC COATING MATERIALS)
    • 5.3     POLYMER BASED STENTS
      • 5.3.1     DURABLE POLYMER BASED STENTS
      • 5.3.2     BIODEGRADABLE POLYMER BASED STENTS
  • 6     STENTS GLOBAL MARKET, BY APPLICATION
    • 6.1     INTRODUCTION
    • 6.2     VASCULAR STENTS
      • 6.2.1     CORONARY ARTERY STENTS
      • 6.2.2     PERIPHERAL ARTERY STENTS
      • 6.2.3     NEUROVASCULAR STENTS
        • 6.2.3.1     CAROTID ARTERY STENTS
        • 6.2.3.2     INTRACRANIAL STENTS
        • 6.2.3.3     FLOW DIVERTER STENTS
      • 6.2.4     RENAL ARTERY STENTS
      • 6.2.5     OTHER VASCULAR STENTS (VENOUS STENTS, VERTEBRAL ARTERY STENTS AND PULMONARY ARTERY STENTS)
    • 6.3     NON-VASCULAR STENTS
      • 6.3.1     GASTROINTESTINAL STENTS
        • 6.3.1.1     PANCREATIC & BILIARY STENTS
        • 6.3.1.2     COLORECTAL STENTS
        • 6.3.1.3     ESOPHAGEAL STENTS
        • 6.3.1.4     DUODENAL STENTS
      • 6.3.2     UROLOGICAL STENTS
      • 6.3.3     AIRWAY STENTS
      • 6.3.4     OTHER NON-VASCULAR STENTS (OPHTHALMIC STENTS)
  • 7     STENTS GLOBAL MARKET, BY END-USERS
    • 7.1     INTRODUCTION
    • 7.2     HOSPITALS
    • 7.3     AMBULATORY SURGERY CENTERS
    • 7.4     OTHER END-USERS (FREESTANDING CATHETERIZATION LABS AND MOBILE CATHETERIZATION LABS AND RESEARCH INSTITUTES)
  • 8     REGIONAL ANALYSIS
    • 8.1     INTRODUCTION
    • 8.2     NORTH AMERICA
      • 8.2.1     U.S.
      • 8.2.2     REST OF NORTH AMERICA
    • 8.3     EUROPE
      • 8.3.1     GERMANY
      • 8.3.2     FRANCE
      • 8.3.3     ITALY
      • 8.3.4     REST OF EUROPE
    • 8.4     APAC
      • 8.4.1     CHINA
      • 8.4.2     JAPAN
      • 8.4.3     INDIA
      • 8.4.4     REST OF APAC
    • 8.5     REST OF THE WORLD
      • 8.5.1     BRAZIL
      • 8.5.2     TURKEY
      • 8.5.3     REST OF LATAM AND MEA
  • 9     COMPETITIVE LANDSCAPE
    • 9.1     INTRODUCTION
    • 9.2     PRODUCT APPROVAL
    • 9.3     CLINICAL STUDIES/INVESTIGATIONS
    • 9.4     PRODUCT LAUNCH
    • 9.5     ACQUISITION
    • 9.6     OTHER DEVELOPMENTS
  • 10     MAJOR COMPANIES
    • 10.1     ABBOTT LABORATORIES
      • 10.1.1     OVERVIEW
      • 10.1.2     FINANCIALS
      • 10.1.3     PRODUCT PORTFOLIO
      • 10.1.4     KEY DEVELOPMENTS
      • 10.1.5     BUSINESS STRATEGY
      • 10.1.6     SWOT ANALYSIS
    • 10.2     B. BRAUN MELSUNGEN AG
      • 10.2.1     OVERVIEW
      • 10.2.2     FINANCIALS
      • 10.2.3     PRODUCT PORTFOLIO
      • 10.2.4     KEY DEVELOPMENTS
      • 10.2.5     BUSINESS STRATEGY
      • 10.2.6     SWOT ANALYSIS
    • 10.3     BECTON, DICKINSON AND COMPANY
      • 10.3.1     OVERVIEW
      • 10.3.2     FINANCIALS
      • 10.3.3     PRODUCT PORTFOLIO
      • 10.3.4     KEY DEVELOPMENTS
      • 10.3.5     BUSINESS STRATEGY
      • 10.3.6     SWOT ANALYSIS
    • 10.4     BIOTRONIK SE & CO. KG
      • 10.4.1     OVERVIEW
      • 10.4.2     FINANCIALS
      • 10.4.3     PRODUCT PORTFOLIO
      • 10.4.4     KEY DEVELOPMENTS
      • 10.4.5     BUSINESS STRATEGY
      • 10.4.6     SWOT ANALYSIS
    • 10.5     BLUE SAIL MEDICAL CO. LTD (BIOSENSORS INTERNATIONAL PTE LTD.)
      • 10.5.1     OVERVIEW
      • 10.5.2     FINANCIALS
      • 10.5.3     PRODUCT PORTFOLIO
      • 10.5.4     KEY DEVELOPMENTS
      • 10.5.5     BUSINESS STRATEGY
      • 10.5.6     SWOT ANALYSIS
    • 10.6     BOSTON SCIENTIFIC CORPORATION
      • 10.6.1     OVERVIEW
      • 10.6.2     FINANCIALS
      • 10.6.3     PRODUCT PORTFOLIO
      • 10.6.4     KEY DEVELOPMENTS
      • 10.6.5     BUSINESS STRATEGY
      • 10.6.6     SWOT ANALYSIS
    • 10.7     CARDINAL HEALTH INC.
      • 10.7.1     OVERVIEW
      • 10.7.2     FINANCIALS
      • 10.7.3     PRODUCT PORTFOLIO
      • 10.7.4     KEY DEVELOPMENTS
      • 10.7.5     BUSINESS STRATEGY
      • 10.7.6     SWOT ANALYSIS
    • 10.8     COOK MEDICAL LLC
      • 10.8.1     OVERVIEW
      • 10.8.2     FINANCIALS
      • 10.8.3     PRODUCT PORTFOLIO
      • 10.8.4     KEY DEVELOPMENTS
      • 10.8.5     BUSINESS STRATEGY
      • 10.8.6     SWOT ANALYSIS
    • 10.9     MEDTRONIC PLC
      • 10.9.1     OVERVIEW
      • 10.9.2     FINANCIALS
      • 10.9.3     PRODUCT PORTFOLIO
      • 10.9.4     KEY DEVELOPMENTS
      • 10.9.5     BUSINESS STRATEGY
      • 10.9.6     SWOT ANALYSIS
    • 10.10     TERUMO CORPORATION
      • 10.10.1     OVERVIEW
      • 10.10.2     FINANCIALS
      • 10.10.3     PRODUCT PORTFOLIO
      • 10.10.4     KEY DEVELOPMENTS
      • 10.10.5     BUSINESS STRATEGY
      • 10.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 2     AVERAGE SELLING PRICE (ASP) OF BARE METAL STENTS, DRUG ELUTING STENTS, COVERED STENTS AND BIORESORBABLE STENTS (2020) ($)
      • TABLE 3     CORONARY STENT IMPLANTATION PROCEDURES, BY REGION, (2019-2027) (NO’S)
      • TABLE 4     PERIPHERAL STENT IMPLANTATION PROCEDURES, BY REGION, (2019-2027) (NO’S)
      • TABLE 5     STENTS GLOBAL MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 6     BARE METAL STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 7     DRUG ELUTING STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 8     BIORESORBABLE STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 9     OTHER STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 10     STENTS GLOBAL MARKET REVENUE, BY MATERIAL, (2019-2027) ($MN)
      • TABLE 11     METAL ALLOY BASED STENTS GLOBAL MARKET REVENUE, BY MATERIAL TYPE, (2019-2027) ($MN)
      • TABLE 12     METAL ALLOY BASED STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 13     COBALT CHROME ALLOY STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 14     NITINOL ALLOY STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 15     STAINLESS STEEL STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 16     PLATINUM ALLOY STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 17     OTHER METAL ALLOY STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 18     POLYMER BASED STENTS GLOBAL MARKET REVENUE, BY MATERIAL TYPE, (2019-2027) ($MN)
      • TABLE 19     POLYMER BASED STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 20     DURABLE POLYMER BASED STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 21     BIODEGRADABLE POLYMER BASED STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 22     STENTS GLOBAL MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 23     VASCULAR STENTS GLOBAL MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 24     VASCULAR STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 25     CORONARY ARTERY STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 26     PERIPHERAL ARTERY STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 27     NEUROVASCULAR STENTS GLOBAL MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 28     NEUROVASCULAR STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 29     CAROTID ARTERY STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 30     INTRACRANIAL STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 31     FLOW DIVERTERS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 32     RENAL ARTERY STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 33     OTHER VASCULAR STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 34     NON-VASCULAR STENTS GLOBAL MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 35     NON-VASCULAR STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 36     GASTROINTESTINAL STENTS GLOBAL MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 37     GASTROINTESTINAL STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 38     PANCREATIC & BILIARY STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 39     COLORECTAL STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 40     ESOPHAGEAL STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 41     DUODENAL STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 42     UROLOGICAL STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 43     AIRWAY STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 44     OTHER NON-VASCULAR STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 45     STENTS GLOBAL MARKET REVENUE, BY END-USERS, (2019-2027) ($MN)
      • TABLE 46     HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 47     AMBULATORY SURGERY CENTERS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 48     OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 49     STENTS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 50     NORTH AMERICA STENTS MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 51     NORTH AMERICA STENTS MARKET REVENUE, BY MATERIAL, (2019-2027) ($MN)
      • TABLE 52     NORTH AMERICA METAL ALLOY BASED STENTS MARKET REVENUE, BY MATERIAL TYPE, (2019-2027) ($MN)
      • TABLE 53     NORTH AMERICA POLYMER BASED STENTS MARKET REVENUE, BY MATERIAL TYPE, (2019-2027) ($MN)
      • TABLE 54     NORTH AMERICA STENTS MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 55     NORTH AMERICA VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 56     NORTH AMERICA NEUROVASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 57     NORTH AMERICA NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 58     NORTH AMERICA GASTROINTESTINAL STENTS MARKET REVENUE, BY APPLICATION TYPE (2019-2027) ($MN)
      • TABLE 59     NORTH AMERICA STENTS MARKET REVENUE, BY END-USERS (2019-2027) ($MN)
      • TABLE 60     NORTH AMERICA STENTS MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 61     EUROPE STENTS MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 62     EUROPE STENTS MARKET REVENUE, BY MATERIAL, (2019-2027) ($MN)
      • TABLE 63     EUROPE METAL ALLOY BASED STENTS MARKET REVENUE, BY MATERIAL TYPE, (2019-2027) ($MN)
      • TABLE 64     EUROPE POLYMER BASED STENTS MARKET REVENUE, BY MATERIAL TYPE, (2019-2027) ($MN)
      • TABLE 65     EUROPE STENTS MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 66     EUROPE VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 67     EUROPE NEUROVASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 68     EUROPE NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 69     EUROPE GASTROINTESTINAL STENTS MARKET REVENUE, BY APPLICATION TYPE (2019-2027) ($MN)
      • TABLE 70     EUROPE STENTS MARKET REVENUE, BY END-USERS (2019-2027) ($MN)
      • TABLE 71     EUROPE STENTS MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 72     APAC STENTS MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 73     APAC STENTS MARKET REVENUE, BY MATERIAL, (2019-2027) ($MN)
      • TABLE 74     APAC METAL ALLOY BASED STENTS MARKET REVENUE, BY MATERIAL TYPE, (2019-2027) ($MN)
      • TABLE 75     APAC POLYMER BASED STENTS MARKET REVENUE, BY MATERIAL TYPE, (2019-2027) ($MN)
      • TABLE 76     APAC STENTS MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 77     APAC VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 78     APAC NEUROVASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 79     APAC NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 80     APAC GASTROINTESTINAL STENTS MARKET REVENUE, BY APPLICATION TYPE (2019-2027) ($MN)
      • TABLE 81     APAC STENTS MARKET REVENUE, BY END-USERS (2019-2027) ($MN)
      • TABLE 82     APAC STENTS MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 83     ROW STENTS MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 84     ROW STENTS MARKET REVENUE, BY MATERIAL, (2019-2027) ($MN)
      • TABLE 85     ROW METAL ALLOY BASED STENTS MARKET REVENUE, BY MATERIAL TYPE, (2019-2027) ($MN)
      • TABLE 86     ROW POLYMER BASED STENTS MARKET REVENUE, BY MATERIAL TYPE, (2019-2027) ($MN)
      • TABLE 87     ROW STENTS MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
      • TABLE 88     ROW VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 89     ROW NEUROVASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 90     ROW NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE, (2019-2027) ($MN)
      • TABLE 91     ROW GASTROINTESTINAL STENTS MARKET REVENUE, BY APPLICATION TYPE (2019-2027) ($MN)
      • TABLE 92     ROW STENTS MARKET REVENUE, BY END-USERS (2019-2027) ($MN)
      • TABLE 93     ROW STENTS MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 94     PRODUCT APPROVAL (2019 – 2020)
      • TABLE 95     CLINICAL STUDIES/INVESTIGATIONS (2019 - 2020)
      • TABLE 96     PRODUCT LAUNCH (2019 – 2020)
      • TABLE 97     ACQUISITION (2019 – 2020)
      • TABLE 98     OTHER DEVELOPMENTS (2019 – 2020)
      • TABLE 99     ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES (2018-2020) ($MN)
      • TABLE 100     ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS (2018-2020) ($MN)
      • TABLE 101     ABBOTT LABORATORIES: MEDICAL DEVICE REVENUE, BY SUB-SEGMENTS (2018-2020) ($MN)
      • TABLE 102     ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY (2018-2020) ($MN)
      • TABLE 103     B.BRAUN MELSUNGEN: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 104     B.BRAUN MELSUNGEN: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 105     B.BRAUN MELSUNGEN: TOTAL REVENUE BY, GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 106     BECTON, DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 107     BECTON, DICKINSON AND COMPANY: TOTAL REVENUE BY PRODUCT SEGMENTS, (2018-2020) ($MN)
      • TABLE 108     BECTON, DICKINSON AND COMPANY: INTERVENTIONAL REVENUE, BY SUB-SEGMENTS, (2018-2020) ($MN)
      • TABLE 109     BECTON, DICKINSON AND COMPANY: TOTAL REVENUE BY GEOGRAPHY, (2018-2020) ($MN)
      • TABLE 110     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2018-2020) ($MN)
      • TABLE 111     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENT, (2018-2020) ($MN)
      • TABLE 112     BOSTON SCIENTIFIC CORPORATION: CARDIOVASCULAR REVENUE BY SUB-SEGMENTS, (2018-2020) ($MN)
      • TABLE 113     BOSTON SCIENTIFIC CORPORATION: MEDSURG REVENUE BY SUB-SEGMENTS, (2018-2020) ($MN)
      • TABLE 114     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
      • TABLE 115     CARDINAL HEALTH: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
      • TABLE 116     CARDINAL HEALTH: TOTAL REVENUE, BY SEGMENTS (2019-2021) ($MN)
      • TABLE 117     CARDINAL HEALTH: MEDICAL REVENUE, BY SUB-SEGMENTS, (2019-2021) ($MN)
      • TABLE 118     CARDINAL HEALTH: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) ($MN)
      • TABLE 119     MEDTRONIC PLC.: TOTAL SALES AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 120     MEDTRONIC PLC.: TOTAL SALES, BY SEGMENTS, (2018-2020) ($MN)
      • TABLE 121     MEDTRONIC PLC: CARDIAC AND VASCULAR GROUP REVENUE, BY SUB-SEGMENTS, (2018-2020) ($MN)
      • TABLE 122     MEDTRONIC PLC: RESTORATIVE THERAPIES GROUP REVENUE, BY SUB-SEGMENTS, (2018-2020) ($MN)
      • TABLE 123     MEDTRONIC PLC.: TOTAL SALES, BY GEOGRAPHY, (2018-2020)($MN)
      • TABLE 124     TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 125     TERUMO CORPORATION: TOTAL REVENUE, BY PRODUCT SEGMENTS, (2018-2020) ($MN)
      • TABLE 126     TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)

      LIST OF FIGURES

      • FIGURE 1     STENTS GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: STENTS GLOBAL MARKET
      • FIGURE 3     STENTS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     STENTS GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     STENTS GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
      • FIGURE 6     STENTS GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     STENTS GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     STENTS: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     STENTS GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2016–2021)
      • FIGURE 11     STENTS CLINICAL TRIAL ANALYSIS
      • FIGURE 12     STENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 13     CORONARY STENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 14     PERIPHERAL STENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 15     NEUROVASCULAR STENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 16     FLOW DIVERTERS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 17     INTRACRANIAL STENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 18     CAROTID STENT GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 19     GASTROINTESTINAL STENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 20     DRUG ELUTING STENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 21     STENTS GLOBAL MARKET SHARE, BY PRODUCT (2020 V/S 2027) (%)
      • FIGURE 22     STENTS GLOBAL MARKET SHARE, BY MATERIAL (2020 V/S 2027) (%)
      • FIGURE 23     METAL ALLOY BASED STENTS GLOBAL MARKET SHARE, BY MATERIAL TYPE (2020 V/S 2027) (%)
      • FIGURE 24     POLYMER BASED STENTS GLOBAL MARKET SHARE, BY MATERIAL TYPE (2020 V/S 2027) (%)
      • FIGURE 25     DURABLE POLYMER BASED STENTS GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%)
      • FIGURE 26     STENTS GLOBAL MARKET SHARE, BY APPLICATION (2020 V/S 2027) (%)
      • FIGURE 27     VASCULAR STENTS GLOBAL MARKET SHARE, BY APPLICATION TYPE (2020 V/S 2027) (%)
      • FIGURE 28     NEUROVASCULAR STENTS GLOBAL MARKET SHARE, BY APPLICATION TYPE (2020 V/S 2027) (%)
      • FIGURE 29     INTRACRANIAL STENTS GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%)
      • FIGURE 30     NON-VASCULAR STENTS GLOBAL MARKET SHARE, BY APPLICATION TYPE (2020 V/S 2027) (%)
      • FIGURE 31     NON-VASCULAR STENTS GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%)
      • FIGURE 32     GASTROINTESTINAL STENTS GLOBAL MARKET SHARE, BY APPLICATION TYPE (2020 V/S 2027) (%)
      • FIGURE 33     ESOPHAGEAL STENTS GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%)
      • FIGURE 34     STENTS GLOBAL MARKET SHARE, BY END-USERS (2020 V/S 2027) (%)
      • FIGURE 35     STENTS GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN), CAGR (%)
      • FIGURE 36     STENTS GLOBAL MARKET SHARE BY REGION AND MARKET REVENUE BY COUNTRY, (2020) (%)
      • FIGURE 37     NORTH AMERICA STENTS MARKET SHARE, BY PRODUCT (2020 V/S 2027) (%)
      • FIGURE 38     NORTH AMERICA STENTS MARKET SHARE, BY MATERIAL AND METAL ALLOY & POLYMER STENTS BY MATERIAL TYPE (2020 V/S 2027) (%)
      • FIGURE 39     NORTH AMERICA STENTS MARKET SHARE, BY APPLICATION (2020 V/S 2027) % AND VASCULAR & NON-VASCULAR STENTS, BY APPLICATION TYPE (2020) (%)
      • FIGURE 40     NORTH AMERICA STENTS MARKET SHARE, BY END-USERS (2020 V/S 2027) (%)
      • FIGURE 41     NORTH AMERICA STENTS MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%)
      • FIGURE 42     U.S. STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 43     U.S. VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
      • FIGURE 44     REST OF NORTH AMERICA STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 45     REST OF NORTH AMERICA VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
      • FIGURE 46     EUROPE STENTS MARKET SHARE, BY PRODUCT (2020 V/S 2027) (%)
      • FIGURE 47     EUROPE STENTS MARKET SHARE, BY MATERIAL AND METAL ALLOY & POLYMER STENTS BY MATERIAL TYPE (2020 V/S 2027) (%)
      • FIGURE 48     EUROPE STENTS MARKET SHARE, BY APPLICATION (2020 V/S 2027) % AND VASCULAR & NON-VASCULAR STENTS BY APPLICATION TYPE (2020) (%)
      • FIGURE 49     EUROPE STENTS MARKET SHARE, BY END-USERS (2020 V/S 2027) (%)
      • FIGURE 50     EUROPE STENTS MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%)
      • FIGURE 51     GERMANY STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 52     GERMANY VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
      • FIGURE 53     FRANCE STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 54     FRANCE VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
      • FIGURE 55     ITALY STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 56     ITALY VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
      • FIGURE 57     REST OF EUROPE STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 58     REST OF EUROPE VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
      • FIGURE 59     APAC STENTS MARKET SHARE, BY PRODUCT (2020 V/S 2027) (%)
      • FIGURE 60     APAC STENTS MARKET SHARE, BY MATERIAL AND METAL ALLOY & POLYMER STENTS BY MATERIAL TYPE (2020 V/S 2027) (%)
      • FIGURE 61     APAC STENTS MARKET SHARE, BY APPLICATION (2020 V/S 2027) % AND VASCULAR & NON-VASCULAR STENTS BY APPLICATION TYPE (2020) (%)
      • FIGURE 62     APAC STENTS MARKET SHARE, BY END-USERS (2020 V/S 2027) (%)
      • FIGURE 63     APAC STENTS MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%)
      • FIGURE 64     CHINA STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 65     CHINA VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
      • FIGURE 66     JAPAN STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 67     JAPAN VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
      • FIGURE 68     INDIA STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 69     INDIA VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
      • FIGURE 70     REST OF APAC STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 71     REST OF APAC VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
      • FIGURE 72     ROW STENTS MARKET SHARE, BY PRODUCT (2020 V/S 2027) (%)
      • FIGURE 73     ROW STENTS MARKET SHARE, BY MATERIAL AND METAL ALLOY & POLYMER STENTS BY MATERIAL TYPE (2020 V/S 2027) (%)
      • FIGURE 74     ROW STENTS MARKET SHARE, BY APPLICATION (2020 V/S 2027) % AND VASCULAR & NON-VASCULAR STENTS BY APPLICATION TYPE (2020) (%)
      • FIGURE 75     ROW STENTS MARKET SHARE, BY END-USERS (2020 V/S 2027) (%)
      • FIGURE 76     ROW STENTS MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%)
      • FIGURE 77     BRAZIL STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 78     BRAZIL VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
      • FIGURE 79     TURKEY STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 80     TURKEY VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
      • FIGURE 81     REST OF LATAM AND MEA STENTS MARKET REVENUE, BY PRODUCT, MATERIAL, APPLICATION AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 82     REST OF LATAM AND MEA VASCULAR AND NON-VASCULAR STENTS MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
      • FIGURE 83     KEY DEVELOPMENTS (2019 –2020)
      • FIGURE 84     SWOT: ABBOTT LABORATORIES
      • FIGURE 85     SWOT: B. BRAUN MELSUNGEN
      • FIGURE 86     SWOT: BECTON, DICKINSON AND COMPANY
      • FIGURE 87     SWOT: BIOTRONIK SE & CO. KG
      • FIGURE 88     SWOT: BLUE SAIL MEDICAL CO. LTD.
      • FIGURE 89     SWOT: BOSTON SCIENTIFIC CORPORATION
      • FIGURE 90     SWOT: CARDINAL HEALTH
      • FIGURE 91     SWOT: COOK MEDICAL INCORPORATED
      • FIGURE 92     SWOT: MEDTRONIC PLC.
      • FIGURE 93     SWOT: TERUMO CORPORATION

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     Abbott Laboratories
      • 2     Abbvie Inc. (Allergan Inc.)
      • 3     Acandis GmbH
      • 4     Accura Medizintechnik GmbH
      • 5     Allium Ltd.
      • 6     Alvimedica
      • 7     AndraTec GmbH
      • 8     Arterius Limited
      • 9     B.Braun Melsungen AG
      • 10     Balt Extrusion
      • 11     Balton Sp. z o.o.
      • 12     Becton, Dickinson and Company
      • 13     Bentley InnoMed GmbH
      • 14     Bess AG
      • 15     Bioteque Corporation
      • 16     Biotronik SE & CO. KG
      • 17     Blue Sail Medical Co. Ltd (Biosensors International Pte Ltd)
      • 18     Boston Scientific Corporation
      • 19     Cardinal Health Inc.
      • 20     CeloNova BioSciences, Inc.
      • 21     Conmed Corporation
      • 22     Cook Medical LLC
      • 23     Disa Vascular (Pty) Ltd. (Disa Medinotec)
      • 24     Dispomedica GmbH
      • 25     Elixir Medical Corporation
      • 26     ELLA - CS, s.r.o
      • 27     Endocor GmbH
      • 28     EndoGI Medical
      • 29     Eucatech AG
      • 30     EuroCor Tech GmbH
      • 31     GENOSS Co., Ltd.
      • 32     Glaukos Corporation
      • 33     Hexacath International
      • 34     Hobbs Medical Inc.
      • 35     HydrUStent SA
      • 36     InspireMD
      • 37     Ivantis Inc.
      • 38     iVascular S.L.U.
      • 39     Kyoto Medical Planning Co. Ltd.
      • 40     Lepu Medical Technology (Beijing) Co., Ltd.
      • 41     M.I.TECH Co., Ltd.      
      • 42     Med pro Medical B.V.
      • 43     Medas Inc.
      • 44     medicut Stent Technology GmbH
      • 45     Medinol Ltd.
      • 46     Medtronic PLC
      • 47     Meril Life Sciences Pvt. Ltd.
      • 48     Merit Medical Systems Inc. (BrightWater Medical)
      • 49     Merlin MD Pte. Ltd.
      • 50     Micell Technologies, Inc. 
      • 51     Micro Medical Solutions
      • 52     Micro Science Medical AG
      • 53     Microport Scientific Corporation
      • 54     Micro-Tech (Nanjing) Co., Ltd.
      • 55     Nanostent
      • 56     Numed Inc.
      • 57     Olympus Corporation
      • 58     optimed Medizinische Instrumente GmbH
      • 59     Opto Circuits (India) Limited
      • 60     OrbusNeich Medical Company Limited
      • 61     Palex Medical SA
      • 62     phenox GmbH
      • 63     plus medica Nordic AB
      • 64     Pnn Medical A/S
      • 65     Poseidon Medical Inc.
      • 66     Q3 Medical Devices Ltd.
      • 67     Relisys Medical Devices Limited
      • 68     REVA Medical Inc.
      • 69     Rontis AG
      • 70     Sahajanand Medical Technologies Pvt. Ltd.
      • 71     Scitech Produtos Médicos SA.
      • 72     Silk Road Medical Inc.
      • 73     Stening Srl
      • 74     Stryker Corporation
      • 75     Svelte Medical Systems Inc.
      • 76     Synlas GmbH & Co.KG
      • 77     Taewoong Medical Co., Ltd.
      • 78     Terumo Corporation
      • 79     Thoracent, Inc.
      • 80     Translumina Therapeutics
      • 81     USM Healthcare Medical Devices Factory JSC
      • 82     Vygon SA (Perouse Medical)
      • 83     W. L. Gore & Associates, Inc.
      • 84     Wellinq Holding B.V.
      • 85     Zhejiang Chuangxiang Medical Technology Co., Ltd.